2m 2m 2m 2m 2m 2m 2m
Insulet (PODD)
NASDAQ
$145.50+$6.53 (+4.70%)
Price as of Jun 23, 2026 7:11 PM EDT- $9.6BMarket Cap
- -54.83%1-Year Change
- Medical DevicesIndustry
Insulet (PODD)
$145.50+$6.53 (+4.70%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.2B +6.03% | 2.1B +22.07% | 1.7B +30.02% | 1.3B +18.79% | |
Cost of Revenue | 768.2M +22.74% | 625.9M +16.51% | 537.2M +7.50% | 499.7M +44.13% | |
Gross Profit | 1.9B +34.18% | 1.4B +24.64% | 1.2B +43.98% | 805.6M +7.11% | |
Sales and Marketing Expense | 1.2B +27.02% | 917.2M +24.81% | 734.9M +25.03% | 587.8M +26.14% | |
Research and Development Expense | -301.1M +37.11% | -219.6M +7.12% | -205.0M +13.76% | -180.2M +12.55% | |
Depreciation and Amortization Expense | 90.4M +11.88% | 80.8M +10.99% | 72.8M +15.19% | 63.2M +10.10% | |
Total Operating Expenses | 768.2M +22.74% | 625.9M +16.51% | 537.2M +7.50% | 499.7M +44.13% | |
Operating Profit | 473.8M +53.38% | 308.9M +40.41% | 220.0M +485.11% | 37.6M -70.16% | |
Interest Income | 34.7M -12.15% | 39.5M +38.11% | 28.6M +191.84% | 9.8M +1,860.00% | |
Interest Expense | -2.6M -18.75% | -3.2M -91.16% | -36.2M +35.58% | -26.7M -56.37% | |
Interest Income and Expense and Net | 32.1M -11.57% | 36.3M +577.63% | -7.6M -55.03% | -16.9M -72.16% | |
Total Nonoperating Income and Expense | 14.3M +360.00% | -5.5M -350.00% | 2.2M +300.00% | -1.1M -42.11% | |
Income before Taxes | 339.5M +13.09% | 300.2M +39.89% | 214.6M +2,089.80% | 9.8M -52.20% | |
Income Taxes | 92.4M +178.24% | -118.1M -1,522.89% | 8.3M +59.62% | 5.2M +40.54% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 247.1M -40.93% | 418.3M +102.76% | 206.3M +4,384.78% | 4.6M -72.62% | |
Net Income from Continuing Operations Applicable to Common | 339.5M +13.09% | 300.2M +39.89% | 214.6M +2,089.80% | 9.8M -52.20% | |
Basic EPS and Net Income | 3.51 -41.21% | 5.97 +101.69% | 2.96 +4,128.57% | 0.07 -72.00% | |
Diluted EPS and Net Income | 3.48 -39.79% | 5.78 +96.60% | 2.94 +4,100.00% | 0.07 -70.83% | |
Basic Weighted Average Shares | 70.3M +0.39% | 70.1M +0.47% | 69.8M +0.54% | 69.4M +2.48% | |
Diluted Weighted Average Shares | 71.9M -2.71% | 73.9M +0.35% | 73.6M +5.33% | 69.9M +1.94% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 716.1M -24.89% | 953.4M +35.39% | 704.2M +2.10% | 689.7M -14.47% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 716.1M -24.89% | 953.4M +35.39% | 704.2M +2.10% | 689.7M -14.47% | |
Total Current Assets | 1.9B +1.20% | 1.9B +19.48% | 1.6B +20.46% | 1.3B -1.19% | |
Accumulated Depreciation | 432.8M +19.43% | 362.4M +23.60% | 293.2M +24.93% | 234.7M +30.97% | |
Property and Plant and Equipment and Net | 819.5M +13.33% | 723.1M +8.75% | 664.9M +10.84% | 599.9M +11.82% | |
Total Long-Term Assets | 205.8M +13.39% | 181.5M -4.47% | 190.0M -9.52% | 210.0M +97.93% | |
Total Assets | 3.2B +3.33% | 3.1B +19.30% | 2.6B +14.97% | 2.3B +9.87% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 18.4M -78.04% | 83.8M +69.64% | 49.4M +79.64% | 27.5M +9.56% | |
Total Current Liabilities | 680.1M +28.71% | 528.4M +17.11% | 451.2M +23.72% | 364.7M +59.40% | |
Total Long-Term Debt | 930.8M -28.18% | 1.3B -5.14% | 1.4B -0.57% | 1.4B +10.05% | |
Total Long-Term Liabilities | 64.4M +24.81% | 51.6M +36.15% | 37.9M +6.16% | 35.7M +139.60% | |
Total Liabilities | 1.7B -10.71% | 1.9B +1.11% | 1.9B +4.55% | 1.8B +18.91% | |
Retained Earnings | 287.4M +613.15% | 40.3M +110.66% | -378.0M -35.31% | -584.3M -10.04% | |
Total Stockholders Equity | 1.5B +25.06% | 1.2B +65.36% | 732.7M +53.80% | 476.4M -14.36% | |
Total Shares Outstanding | 70.4M +0.28% | 70.2M +0.41% | 69.9M +0.57% | 69.5M +0.48% | |
Cash Flow | |||||
Cash from Operating Activities | 569.3M +32.30% | 430.3M +195.33% | 145.7M +22.44% | 119.0M +274.74% | |
Capital Expenditures | 191.6M +53.40% | 124.9M +65.21% | 75.6M -38.49% | 122.9M +9.83% | |
Cash from Investing Activities | -222.7M +52.33% | -146.2M +22.45% | -119.4M -37.52% | -191.1M +131.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -595.3M +2,018.51% | -28.1M +106.62% | -13.6M -66.25% | -40.3M -199.02% | |
Financials Ratio | |||||
Gross Margin | 65.03% -6.82% | 69.79% +2.11% | 68.35% +10.74% | 61.72% -9.83% | |
Operating Margin | 21.57% +44.66% | 14.91% +15.03% | 12.96% +350.02% | 2.88% -74.88% | |
Return on Assets | 7.87% -46.59% | 14.74% +72.88% | 8.53% +3,884.11% | 0.21% -75.02% | |
Return on Equity | 18.12% -57.88% | 43.03% +26.09% | 34.12% +3,730.35% | 0.89% -69.25% | |
Revenue Growth | 6.03% -72.68% | 22.07% -26.48% | 30.02% +59.72% | 18.79% -12.57% | |
Current Ratio | 2.81 -21.37% | 3.58 +2.03% | 3.51 -2.63% | 3.60 -38.01% | |
Cash Ratio | 1.05 -41.64% | 1.80 +15.61% | 1.56 -17.47% | 1.89 -46.34% | |
Debt-to-Equity Ratio | 0.63 -44.99% | 1.14 -41.06% | 1.93 -34.33% | 2.94 +28.49% | |
Debt-to-Assets Ratio | 0.30 -33.43% | 0.45 -18.30% | 0.55 -12.16% | 0.62 +0.14% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow